All articles by Divya Tirumalaraju

  1. Sanofi faces formal investigation over epilepsy drug Depakine

    Healthcare company Sanofi Aventis France is facing formal investigation regarding charges of manslaughter over epilepsy drug Depakine (valproate). The drug…
    Read More…

    4 Aug
  2. Janssen gets FDA approval for Spravato spray for depressive symptoms

    Janssen Pharmaceutical has received approval from the US Food and Drug Administration (FDA) for Spravato (esketamine) CIII nasal spray for…
    Read More…

    4 Aug
  3. UK teams up with Wockhardt for vaccine manufacturing services

    The UK Government has partnered with India-based pharmaceutical company Wockhardt for ‘fill and finish’ services to boost vaccine manufacturing in…
    Read More…

    3 Aug
  4. Roche’s Rozlytrek gets EC approval to treat solid tumours and NSCLC

    Roche has received conditional marketing approval from the European Commission (EC) for Rozlytrek (entrectinib) to treat solid tumours in patients…
    Read More…

    3 Aug
  5. Pfizer and BioNTech to supply 120 million Covid-19 vaccine doses to Japan

    Pfizer and BioNTech have entered an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to provide 120 million…
    Read More…

    3 Aug
  6. US commits $2.1bn for 100 million Sanofi-GSK Covid-19 vaccine doses

    The US Government has committed to providing up to $2.1bn to Sanofi and GlaxoSmithKline (GSK) for development, manufacturing, scale-up and…
    Read More…

    31 Jul
  7. Teva-Takeda joint venture divests certain assets in Japan to Nichi-Iko

    A business joint venture (BV) comprising Teva Pharmaceutical and Takeda Pharmaceutical in Japan is set to divest the majority of…
    Read More…

    31 Jul
  8. Novartis partners with Sangamo on genomic therapies

    Novartis has signed an exclusive, global licensing collaboration agreement with Sangamo Therapeutics to develop and commercialise genomic therapies for neurodevelopmental…
    Read More…

    31 Jul
  9. J&J begins first trial of Covid-19 vaccine after positive preclinical data

    Johnson & Johnson (J&J) has started a Phase I/IIa clinical trial of its Covid-19 vaccine candidate, Ad26.COV2.S, in healthy volunteers…
    Read More…

    30 Jul
  10. Intravacc and Celonic team up to develop Covid-19 vaccine

    Intravacc has partnered with contract development and manufacturing organisation (CDMO) Celonic Group for the design, development and production of a…
    Read More…

    30 Jul
Close
Close
Close

Go Top